Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Sep;7(9):1409-15.
doi: 10.2215/CJN.03210312. Epub 2012 Jun 28.

Urolithiasis and the risk of ESRD

Affiliations

Urolithiasis and the risk of ESRD

Ziad M El-Zoghby et al. Clin J Am Soc Nephrol. 2012 Sep.

Abstract

Background and objectives: The contribution of urolithiasis, if any, to the development of ESRD is unclear.

Design, setting, participants, & measurements: All stone formers in Olmsted County, Minnesota, first diagnosed between 1984 and 2008 were identified by diagnostic codes with up to four controls matched on age and sex. Charts were reviewed to validate symptomatic stone formers in a random subset. Incident ESRD events were identified by the US Renal Data System.

Results: Altogether, 51 stone formers and 75 controls developed ESRD among 6926 stone formers and 24,620 matched controls followed for a mean of 9 years. Stone formers had an increased risk of ESRD after adjusting for diabetes, hypertension, dyslipidemia, gout, and CKD (hazard ratio: 2.09; 95% confidence interval: 1.45-3.01). This increased risk of ESRD remained in the subset of 2457 validated symptomatic stone formers (hazard ratio: 1.95; 95% confidence interval: 1.09-3.49). The attributable risk of ESRD from symptomatic urolithiasis was 5.1% based on a prevalence of 5.4% for stone formers. For stone formers versus controls who developed ESRD, there was an increased likelihood of past hydronephrosis (44% versus 4%), recurrent urinary tract infections (26% versus 4%), acquired single kidney (15% versus 3%), neurogenic bladder (12% versus 1%), and ileal conduit (9% versus 0%), but not diabetes (32% versus 49%) or hypertension (44% versus 52%).

Conclusions: Symptomatic stone formers are at increased risk for ESRD independent of several cardiovascular risk factors. Other urological disease is relatively common among stone formers who develop ESRD.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Risk of ESRD is in stone formers versus matched controls. Cumulative incidence (Kaplan–Meier method) of ESRD is significantly higher among the ICD-9–coded stone formers versus matched controls in (A) analysis group 2 (P=0.001), and also among the validated symptomatic stone formers versus matched controls who comprised (B) group 4 (P=0.01) in Olmsted County, Minnesota, from 1984 to 2003. ICD-9, International Classification of Diseases, Ninth Revision.

Similar articles

  • Risk of ESRD and Mortality in Kidney and Bladder Stone Formers.
    Dhondup T, Kittanamongkolchai W, Vaughan LE, Mehta RA, Chhina JK, Enders FT, Hickson LJ, Lieske JC, Rule AD. Dhondup T, et al. Am J Kidney Dis. 2018 Dec;72(6):790-797. doi: 10.1053/j.ajkd.2018.06.012. Epub 2018 Aug 23. Am J Kidney Dis. 2018. PMID: 30146423 Free PMC article.
  • Risk of Hypertension among First-Time Symptomatic Kidney Stone Formers.
    Kittanamongkolchai W, Mara KC, Mehta RA, Vaughan LE, Denic A, Knoedler JJ, Enders FT, Lieske JC, Rule AD. Kittanamongkolchai W, et al. Clin J Am Soc Nephrol. 2017 Mar 7;12(3):476-482. doi: 10.2215/CJN.06600616. Epub 2017 Feb 1. Clin J Am Soc Nephrol. 2017. PMID: 28148559 Free PMC article.
  • Kidney stones and the risk for chronic kidney disease.
    Rule AD, Bergstralh EJ, Melton LJ 3rd, Li X, Weaver AL, Lieske JC. Rule AD, et al. Clin J Am Soc Nephrol. 2009 Apr;4(4):804-11. doi: 10.2215/CJN.05811108. Epub 2009 Apr 1. Clin J Am Soc Nephrol. 2009. PMID: 19339425 Free PMC article.
  • Nephrolithiasis and loss of kidney function.
    Keddis MT, Rule AD. Keddis MT, et al. Curr Opin Nephrol Hypertens. 2013 Jul;22(4):390-6. doi: 10.1097/MNH.0b013e32836214b9. Curr Opin Nephrol Hypertens. 2013. PMID: 23736840 Free PMC article. Review.
  • Chronic kidney disease in kidney stone formers.
    Rule AD, Krambeck AE, Lieske JC. Rule AD, et al. Clin J Am Soc Nephrol. 2011 Aug;6(8):2069-75. doi: 10.2215/CJN.10651110. Epub 2011 Jul 22. Clin J Am Soc Nephrol. 2011. PMID: 21784825 Free PMC article. Review.

Cited by

References

    1. Rule AD, Bergstralh EJ, Melton LJ, 3rd, Li X, Weaver AL, Lieske JC: Kidney stones and the risk for chronic kidney disease. Clin J Am Soc Nephrol 4: 804–811, 2009 - PMC - PubMed
    1. Gillen DL, Worcester EM, Coe FL: Decreased renal function among adults with a history of nephrolithiasis: A study of NHANES III. Kidney Int 67: 685–690, 2005 - PubMed
    1. Vupputuri S, Soucie JM, McClellan W, Sandler DP: History of kidney stones as a possible risk factor for chronic kidney disease. Ann Epidemiol 14: 222–228, 2004 - PubMed
    1. Chen N, Wang W, Huang Y, Shen P, Pei D, Yu H, Shi H, Zhang Q, Xu J, Lv Y, Fan Q: Community-based study on CKD subjects and the associated risk factors. Nephrol Dial Transplant 24: 2117–2123, 2009 - PMC - PubMed
    1. Rule AD, Krambeck AE, Lieske JC: Chronic kidney disease in kidney stone formers. Clin J Am Soc Nephrol 6: 2069–2075, 2011 - PMC - PubMed

Publication types